Tob Control 1998;7:281-293 ( Autumn )

From the American Medical Association

Reducing the addictiveness of cigarettes Jack E Henningfield, Neal L Benowitz, John Slade, Thomas P Houston, Ronald M Davis, Scott D Deitchman, for the Council on Scientific Affairs, American Medical Association

OBJECTIVETo assess the feasibility of reducing tobacco-caused disease by gradually removing nicotine from cigarettes until they would not be effective causes of nicotine addiction.
DATA SOURCESIssues posed by such an approach, and potential solutions, were identified from analysis of literature published by the US Food and Drug Administration (FDA) in its 1996 Tobacco Rule, comments of the tobacco industry and other institutions and individuals on the rule, review of the reference lists of relevant journal articles, other government publications, and presentations made at scientific conferences.
DATA SYNTHESISThe role of nicotine in causing and sustaining tobacco use was evaluated to project the impact of a nicotine reduction strategy on initiation and maintenance of, and relapse to, tobacco use. A range of potential concerns and barriers was addressed, including the technical feasibility of reducing cigarette nicotine content to non-addictive levels, the possibility that compensatory smoking would reduce potential health benefits, and whether such an approach would foster illicit ("black market") tobacco sales. Education, treatment, and research needs to enable a nicotine reduction strategy were also addressed. The Council on Scientific Affairs came to the following conclusions: (a) gradually eliminating nicotine from cigarettes is technically feasible; (b) a nicotine reduction strategy holds great promise in preventing adolescent tobacco addiction and assisting the millions of current cigarette smokers in their efforts to quit using tobacco products; (c) potential problems such as compensatory over-smoking of denicotinised cigarettes and black market sales could be minimised by providing alternate forms of nicotine delivery with less or little risk to health, as part of expanded access to treatment; and (d) such a strategy would need to be accompanied by relevant research and increased efforts to educate consumers and health professionals about tobacco and health.
CONCLUSIONSThe council recommends the following: (a) that cessation of tobacco use should be the goal for all tobacco users; (b) that the American Medical Association continue to support FDA authority over tobacco products, and FDA classification of nicotine as a drug and tobacco products as drug-delivery devices; (c) that research be encouraged on cigarette modifications that may result in less addicting cigarettes; (d) that the FDA require that the addictiveness of cigarettes be reduced within 5-10 years; (e) expanded surveillance to monitor trends in the use of tobacco products and other nicotine-containing products; (f) expanded access to smoking cessation treatment, and strengthening of the treatment infrastructure; and (g) more accurate labelling of tobacco products, including a more meaningful and understandable indication of nicotine content.


Keywords: American Medical Association; addiction; nicotine; smoking cessation

---

© 1998 by Tobacco Control
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Taking aim at the bull's-eye: the nicotine in tobacco products

CLIFFORD E DOUGLAS
Tob. Control 1998 7: 215-218. [Extract] [Full Text] [PDF]

Dark secrets of tobacco company exposed

TODD LEWAN
Tob. Control 1998 7: 315-319. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Zeller, M., Hatsukami, D., and the Strategic Dialogue on Tobacco Harm Reducti, (2009). The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tobacco Control 18: 324-332 [Abstract] [Full Text]  
• Fiore, M. C., Baker, T. B. (2009). Stealing a March in the 21st Century: Accelerating Progress in the 100-Year War Against Tobacco Addiction in the United States. AJPH 99: 1170-1175 [Abstract] [Full Text]  
• Benowitz, N. L., Dains, K. M., Hall, S. M., Stewart, S., Wilson, M., Dempsey, D., Jacob, P. III (2009). Progressive Commercial Cigarette Yield Reduction: Biochemical Exposure and Behavioral Assessment. Cancer Epidemiol. Biomarkers Prev. 18: 876-883 [Abstract] [Full Text]  
• Benowitz, N. L., Hall, S. M., Stewart, S., Wilson, M., Dempsey, D., Jacob, P. III (2007). Nicotine and Carcinogen Exposure with Smoking of Progressively Reduced Nicotine Content Cigarette. Cancer Epidemiol. Biomarkers Prev. 16: 2479-2485 [Abstract] [Full Text]  
• Connolly, G. N, Alpert, H. R, Wayne, G. F., Koh, H. (2007). Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997 2005. Tobacco Control 16: e5-e5 [Abstract] [Full Text]  
• Wang, S. N., Liu, Z., Tang, H. Z., Meng, J., Xu, P. (2007). Characterization of environmentally friendly nicotine degradation by Pseudomonas putida biotype A strain S16. Microbiology 153: 1556-1565 [Abstract] [Full Text]  
• Cummings, K M., Brown, A., Douglas, C. E (2006). Consumer acceptable risk: how cigarette companies have responded to accusations that their products are defective. Tobacco Control 15: iv84-iv89 [Abstract] [Full Text]  
• Gray, N, Henningfield, J E, Benowitz, N L, Connolly, G N, Dresler, C, Fagerstrom, K, Jarvis, M J, Boyle, P (2005). Toward a comprehensive long term nicotine policy. Tobacco Control 14: 161-165 [Abstract] [Full Text]  
• Dunsby, J, Bero, L (2004). A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes. Tobacco Control 13: 362-369 [Abstract] [Full Text]  
• Henningfield, J E, Benowitz, N L, Connolly, G N, Davis, R M, Gray, N, Myers, M L, Zeller, M (2004). Reducing tobacco addiction through tobacco product regulation. Tobacco Control 13: 132-135 [Abstract] [Full Text]  
• Sumner, W II (2003). Estimating the health consequences of replacing cigarettes with nicotine inhalers. Tobacco Control 12: 124-132 [Abstract] [Full Text]  
• Henningfield, J E, Moolchan, E T, Zeller, M (2003). Regulatory strategies to reduce tobacco addiction in youth. Tobacco Control 12: i14-24 [Abstract] [Full Text]  
• Davis, R. M (2000). Moving tobacco control beyond "the tipping point". BMJ 321: 309-310 [Full Text]  
• Gray, N. (2000). Reflections on the saga of tar content: why did we measure the wrong thing?. Tobacco Control 9: 90-94 [Full Text]  
• JOOSSENS, L., HAYES;, A., HENNINGFIELD, J. E, SLADE, J. (1999). Eliminating the nicotine in cigarettes. Tobacco Control 8: 223-224 [Full Text]  
• Bates, C., McNeill, A., Jarvis, M., Gray, N. (1999). The future of tobacco product regulation and labelling in Europe: implications for the forthcoming European Union directive. Tobacco Control 8: 225-235 [Full Text]  
• DAVIS, R. M (1999). Tobacco Control: reflections on the first seven years. Tobacco Control 8: 1-9 [Full Text]  
• SHATENSTEIN;, S., JARVIS, M. J, BATES;, C., LAUGESEN;, M., HENNINGFIELD, J. E, DAVIS, R. M, HOUSTON, T. P, BENOWITZ, N. L, SLADE;, J., DOUGLAS, C. E (1999). Eliminating nicotine in cigarettes. Tobacco Control 8: 106-109 [Full Text]